ATCO Pharma
人用和兽用药品制造
ATCO Pharma 在埃及生产人用药品、兽药产品和饲料添加剂。该公司为国内和区域市场的医疗保健、兽医和药品分销渠道提供服务。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cairo, Egypt
- Founded
- 1999
- Website
- https://www.atcopharma.com.eg
- Categories
- 医疗保健用品, 农业及原材料, 兽医产品和动物保健
- Markets
- 埃及, 沙特阿拉伯, 阿拉伯联合酋长国
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- named-by-manufacturer (green), effective since 2026-07-03 Celltrion distributor list
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)